Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051701
Status:
TERMINATED
Last Update Posted:
2015-03-05
First Post:
2003-01-15
Brief Title:
Phase III Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkins Lymphoma
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
CAMNHL232
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Monitor
Old Organization:
Genzyme Corporation